Vilazodone

Vilazodone is a selective serotonin reuptake inhibitor (SSRI) and partial serotonin receptor agonist that is used in the therapy of major depressive disorders. In premarketing clinical trials, vilazodone therapy was not associated with an increased rate of elevations in serum aminotransferase levels, and it has yet to be linked to instances of clinically apparent acute liver injury. Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors. Vilazodone may also be associated with less sexual dysfunction and weight gain. It is grouped under the following drug class(es): Psychotropic agents, Selective Serotonin Reuptake Inhibitors and Serotonin agents. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vilazodona and Vilazodonum. Its PubChem CID is 6918314.

CAS No 163521-12-8
Molecular Formula C26H27N5O2
Molecular Weight 441.5 g/mol
Synonyms 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide

Frequently Asked Questions